Tryptamine Therapeutics Updates Financial Statements

Tryptamine Therapeutics (AU:TYP) has released an update.

Tryptamine Therapeutics Inc. has amended its interim consolidated financial statements for the six-month period ending February 29, 2024. Key financial documents such as statements of financial position, comprehensive loss, shareholders’ equity, and cash flows have been updated. This could indicate significant changes in the company’s financial health, which may interest investors.

For further insights into AU:TYP stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.